Free Trial

Zevia PBC (NYSE:ZVIA) CEO Amy Taylor Buys 55,000 Shares

→ Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad)
Zevia PBC logo with Medical background

Zevia PBC (NYSE:ZVIA - Get Free Report) CEO Amy Taylor bought 55,000 shares of the business's stock in a transaction that occurred on Friday, May 10th. The stock was purchased at an average price of $0.89 per share, with a total value of $48,950.00. Following the completion of the purchase, the chief executive officer now directly owns 1,014,252 shares in the company, valued at approximately $902,684.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Amy Taylor also recently made the following trade(s):

  • On Tuesday, March 26th, Amy Taylor sold 30,703 shares of Zevia PBC stock. The stock was sold at an average price of $1.02, for a total transaction of $31,317.06.

Zevia PBC Price Performance

NYSE:ZVIA traded up $0.15 during mid-day trading on Tuesday, reaching $1.08. The stock had a trading volume of 296,749 shares, compared to its average volume of 164,786. The stock has a 50-day simple moving average of $1.06 and a two-hundred day simple moving average of $1.58. The stock has a market capitalization of $77.60 million, a PE ratio of -2.15 and a beta of 0.66. Zevia PBC has a 12 month low of $0.78 and a 12 month high of $4.80.

Zevia PBC (NYSE:ZVIA - Get Free Report) last announced its quarterly earnings data on Wednesday, May 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.10). The business had revenue of $38.80 million for the quarter, compared to analysts' expectations of $39.82 million. Zevia PBC had a negative net margin of 15.58% and a negative return on equity of 37.98%. During the same period last year, the firm posted ($0.04) earnings per share. Equities analysts expect that Zevia PBC will post -0.36 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Telsey Advisory Group cut their price objective on shares of Zevia PBC from $3.00 to $2.00 and set a "market perform" rating for the company in a research report on Thursday, May 9th. The Goldman Sachs Group cut their price objective on shares of Zevia PBC from $3.00 to $1.25 and set a "neutral" rating for the company in a research report on Thursday, May 9th. Wells Fargo & Company cut their price objective on shares of Zevia PBC from $1.25 to $1.00 and set an "equal weight" rating for the company in a research report on Thursday, May 9th. Finally, Morgan Stanley cut their price objective on shares of Zevia PBC from $3.00 to $2.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 28th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $3.21.


Get Our Latest Stock Analysis on Zevia PBC

Institutional Trading of Zevia PBC

Hedge funds and other institutional investors have recently modified their holdings of the stock. Allspring Global Investments Holdings LLC bought a new stake in shares of Zevia PBC during the third quarter worth $31,000. Sapient Capital LLC bought a new stake in shares of Zevia PBC during the fourth quarter worth $41,000. Finally, Kennedy Capital Management LLC grew its stake in shares of Zevia PBC by 51.7% during the third quarter. Kennedy Capital Management LLC now owns 645,041 shares of the company's stock worth $1,432,000 after buying an additional 219,932 shares during the last quarter. Institutional investors own 53.21% of the company's stock.

About Zevia PBC

(Get Free Report)

Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.

See Also

Insider Buying and Selling by Quarter for Zevia PBC (NYSE:ZVIA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Zevia PBC right now?

Before you consider Zevia PBC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.

While Zevia PBC currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Splits: A Beginner’s Guide
Buy or Bail? Stock Upgrades and Downgrades
Profit Like Congress: The Stocks They’re Betting On

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines